[1]
Khan, H.R. et al. 2025. COMPARISON OF EFFICACY OF DAPAGLIFLOZIN METFORMIN VERSUS SITAGLIPTIN METFORMIN IN NEWLY DIAGNOSED TYPE 2 DIABETES. Insights – Journal of Health and Rehabilitation. 3, 1 (Feb. 2025), 329–336. DOI:https://doi.org/10.71000/hxwms012.